216 results
Page 2 of 11
SC 14D9
g9umof
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
xmgvv09d 1xv14cm8m
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-C
EX-99.1
4v3tcz4i9k65b99xzbb
31 May 22
Information about tender offer
10:02am
SC14D9C
EX-99.1
dlwp0optdb9kl
31 May 22
Written communication relating to third party tender offer
7:55am
8-K
EX-99.1
8fwog6
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-99.1
ca2u pop0
20 May 22
Regulation FD Disclosure
10:30am
8-K
EX-99.1
dh3atv21iq si
14 Apr 22
TherapeuticsMD completes the divestiture of vitaCare Prescription Services to GoodRx in a cash transaction valued at $150 million
4:25pm
POS AM
8j9ynkabtsggi q9f
23 Mar 22
Prospectus update (post-effective amendment)
6:06pm
POSASR
5m6p48r3
23 Mar 22
Automatic shelf registration (post-effective amendment)
4:37pm
8-K
EX-99.1
2u74nccxpx vqu
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.2
lyrnv8c70vviya
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
tw4xoh4
7 Mar 22
TherapeuticsMD Enters into a Definitive Agreement to Divest vitaCare to GoodRx
7:47am
8-K
EX-99.1
yzas4f6j tydp
10 Dec 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
ssxkty0pbyylf7
8 Dec 21
Regulation FD Disclosure
6:55am
8-K/A
EX-99.1
wx79g11w4x
16 Nov 21
Results of Operations and Financial Condition
6:30am
8-K
EX-99.1
f6tggaa0mw4zsqq
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
8-K
EX-99.3
akevlfr18wep nvw6
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am